Oruka Therapeutics Inc - ORKA Sales Growth YoY (TTM)

Public company logo of orukatx.com (ORKA)

Oruka Therapeutics Inc (ORKA) potential for superprofits is based on the creation of unique targeted molecules. The annual revenue growth dynamics over the TTM period visualize this trajectory, where the latest parameter stands at 0.00. Stable margins are ensured by patent protection of formulas for psoriasis therapy, while expansion is supported by growing demand for long-term treatment of chronic dermatological pathologies in an undersaturated segment.

ORKA Oruka Therapeutics: Sales Growth YoY (TTM) in the range 11/23/2025 - 11/19/2026

Oruka Therapeutics Inc - analytical breakdowns and key metrics (ORKA)

Summary company analytics:Oruka Corp
Brand item of Oruka Pharma

Oruka Therapeutics Inc (ORKA) leads the development of long-acting antibodies for the treatment of dermatological diseases, which defines the specifics of its scaling. By analyzing the 12-month trailing revenue changes compared to the previous year, an investor assesses business expansion rates through the percentage deviation of the rolling annual income, where excessive acceleration may signal an increase in operational risks during the expansion of innovative drugs.